Company Filing History:
Years Active: 2007-2013
Title: Ian Peter Holmes: Innovator in Matrix Metalloproteinase Inhibitors
Introduction
Ian Peter Holmes is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of matrix metalloproteinase inhibitors. With a total of 6 patents to his name, Holmes has established himself as a key figure in his area of expertise.
Latest Patents
Holmes' latest patents focus on compounds that serve as inhibitors of matrix metalloproteinase enzymes (MMPs). The inventions relate to compounds of Formula (I) and their pharmaceutically acceptable salts. These patents also cover corresponding preparation processes, pharmaceutical formulations, and methods for use as inhibitors of MMPs. His work in this area is crucial for advancing therapeutic options in various medical conditions.
Career Highlights
Ian Peter Holmes is associated with Glaxo Group Limited, where he has been instrumental in research and development. His innovative work has contributed to the company's reputation as a leader in the pharmaceutical industry. Holmes' dedication to his field is evident through his numerous patents and ongoing research efforts.
Collaborations
Holmes has collaborated with notable colleagues, including Stephen Paul Watson and Simon Gaines. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Ian Peter Holmes is a distinguished inventor whose work in matrix metalloproteinase inhibitors has made a significant impact in the pharmaceutical industry. His contributions continue to pave the way for advancements in medical treatments.